Authors
Latest:
Psychologist Prescribing Privileges in Oregon: A Potentially Dangerous Non-solutionAs a fellow Oregonian, I concur with Dr Jim Phelps that the topic of psychologist prescribing is highly complex, and that even balanced opinions generate “affective discharge” approaching “invective."
Latest:
Neurostimulation Treatments in Psychiatry: An Overview and Recent AdvancesThere have been considerable advances in the research on and clinical use of neurostimulation for psychiatric disorders, especially mood disorders and MDD. Three of the most recognized are reviewed here. An experimental new treatment-- trigeminal nerve stimulation-- is also briefly discussed.
Latest:
Child and Adolescent Psychiatry: The Next 10 YearsPsychiatry is changing so rapidly that it seems impossible to predict 1 year ahead, let alone 10 years. In 1967, when my psychiatry training ended, the community psychiatry movement had just begun, DSM-II was in the works, and the biological revolution was still around the corner.
Latest:
What Are Best Practices for Psychiatrists When Serving As Expert Witnesses?An expert shares 7 tips for effectively serving as an expert witness in court.
Latest:
Drs McGlashan and Woods Respond to Dr FeinbergDr Feinberg takes exception to much of what we wrote, or what he thinks we wrote, in our article “Early Antecedents and Detection in Schizophrenia”. We will do our best to reply to his criticisms of what we did write and try to point out where he is shadowboxing at issues that he has created but that we do not hold or endorse.
Latest:
The Muscarinic Hypothesis of SchizophreniaSince the discovery of dopamine as a neurotransmitter in the late 1950s, schizophrenia has been associated with changes in the dopaminergic system. However, the dopamine hypothesis of schizophrenia cannot explain all the symptoms associated with this disorder. Therefore, research has also focused on the role of other neurotransmitter systems, including glutamate, g-aminobutyric acid, serotonin, and acetylcholine (ACh) in schizophrenia.
Latest:
Understanding and Overcoming the Myths of SuicideWhat goes on in the minds of those who attempt suicide? Here: a psychologist who explores the myths that surround suicide notes "We need to get it in our heads that suicide is not easy, painless, cowardly, selfish, vengeful, self-masterful, nor rash."
Latest:
Introduction: Looking to the Future of PsychopharmacologyThe focus of this Special Report is on some future-oriented aspects of psychopharmacology. First, it is an eclectic set of articles that cover treating resistant depression, using currently illegal drugs to treat psychiatric problems, and finally the potential of using vaccines to treat substance use disorders.
Latest:
The OPTICS Project: An Open-Science Framework for the Analysis of Clinical Trial DataA report of initiatives that have raised awareness of and promoted data sharing and data transparency in order to advance science and improve public health and health care.
Latest:
The Therapeutic Alliance and Psychosocial Interventions for Successful Treatment of AddictionA discussion of treatment options to help foster the most effective psychosocial treatment for addiction.
Latest:
Accept Insurance? I Wish I CouldThere are not enough participating psychiatrists to accommodate all who would seek treatment if it were affordable. This is not a good situation.
Latest:
Federal Court Gives Green Light to Deny Coverage"With our country’s ongoing mental health and addiction crisis, the consequences of the Wit v UBH reversal are too great to ignore."
Latest:
Stress and Substance Use Among Drag PerformersWhat influence do legislation and social-based decisions have on individual mental health, like in the case of drag performers?
Latest:
Marketing Off-Label Uses: Shady Practices Within a Gray MarketFor pharmaceutical companies, off-label use of a drug represents a substantial “gray market,” to which the company is unable to sell their product directly, yet may be a significant revenue stream. Some drugs have been used more for off-label purposes than for originally approved indications.1
Latest:
Diagnosing Dementia: Essential for Prognosis, Treatment, and Potential CureDefined as a clinical syndrome involving progressive deterioration in multiple areas of cognitive functioning, dementia is a major cause of disability, institutionalization, and increased mortality among the elderly. Although it can occur in younger persons too, dementia is typically associated with aging. It is often seen as a disease that cannot be prevented or cured. However, there is increasing evidence that some types of dementia can be successfully treated or even reversed.
Latest:
Hypothyroidism: An Important Diagnostic Consideration for the PsychiatristHypothyroidism is a common clinical disorder that psychiatrists frequently encounter. However, symptoms of thyroid dysfunction are often vague and nonspecific, which can lead to delayed or missed diagnosis.
Latest:
Group Therapy and Cancer Survival-- Where Does the Evidence Lie in 2007?One of the most hotly debated questions within oncology over the past decade has been whether the promotion of psychological wellness can extend survival for patients with advanced cancer. The converse--that psychiatric disorder shortens survival--seems true, with mechanisms of poor self-care and reduced adherence to anticancer treatments resultant from depressive or psychotic disorders explaining this outcome.
Latest:
Emerging Treatments and Pharmacogenetics for Cocaine Use DisorderThere are no FDA-approved pharmacotherapies for cocaine use disorder. Here: a review of the off-label use of promising medications for this addiction.
Latest:
Managing the Psychiatric Manifestations of Parkinson Disease: An UpdateParkinson disease (PD) is a progressive neurodegenerative disorder affecting 1% of people 65 years and older. The core symptoms include the motor manifestations of tremor, bradykinesia, and rigidity.
Latest:
Lithium Therapy, Bipolar Disorder- and NeurocognitionFunctional mood stability can be attained with lithium therapy, but guidelines on how to get there have become increasingly sophisticated.
Latest:
Why Are Young Westerners Drawn to Terrorist Organizations Like ISIS?The authors explore possible reasons why young people in the West leave their families, friends, and home culture to join terrorist organizations.
Latest:
The Links Between PTSD and Eating DisordersDespite an abundance of studies linking both traumatic experiences and anxiety disorders with eating disorders, relatively little has been reported on the prevalence of associated posttraumatic stress disorder (PTSD) or partial PTSD in patients with eating disorders.
Latest:
On Leadership and Holding the LanternIn this incredible era of breakthroughs in neuroscience and its applied therapies, psychiatrists have been recognized as leaders and pioneers in battling the previously elusive maladies of the human condition. In the darkness, people instinctively follow the person carrying the lantern. As a consequence, I am not necessarily sure where we're going.
Latest:
Bedlam: London and Its MadAs expected from an Oxbridge graduate, author Catharine Arnold’s Bedlam: London and Its Mad is a well-written and very readable book. “This book is for all whose lives are touched by madness” is a laudable objective.
Latest:
Preadoption Risk FactorsAlthough adoption dates back centuries, the issue of whether or not adopted children are at risk for psychological maladjustment remains controversial. That this dispute would occur at all is not surprising, since as recently as 1926 laws which liberalized adoptions in England were faced with a widespread objection that adoption would encourage depraved conduct.
Latest:
Prevention and Treatment of AddictionIn 2006, substance dependence or abuse was diagnosed in about 22.6 million persons in the United States.1 Addiction-related morbidity and mortality pose a major burden to society, costing our economy more than $500 billion annually: about $181 billion for illicit drugs,2 $168 billion for tobacco,3 and $185 billion for alcohol.4
Latest:
Marketing Off-Label Uses: Shady Practices Within a Gray MarketFor pharmaceutical companies, off-label use of a drug represents a substantial “gray market,” to which the company is unable to sell their product directly, yet may be a significant revenue stream. Some drugs have been used more for off-label purposes than for originally approved indications.1
Latest:
Addressing Myths and Facts About Cannabis UseTimothy W. Fong, MD, touches on our current understanding about cannabis use for psychiatric disorders.
